Hydroxychloroquine Therapy in Sarcoidosis-Associated Uveitis.
Hydroxychloroquine
sarcoidosis
uveitis
Journal
Ocular immunology and inflammation
ISSN: 1744-5078
Titre abrégé: Ocul Immunol Inflamm
Pays: England
ID NLM: 9312169
Informations de publication
Date de publication:
07 Feb 2023
07 Feb 2023
Historique:
entrez:
7
2
2023
pubmed:
8
2
2023
medline:
8
2
2023
Statut:
aheadofprint
Résumé
To assess the efficacy and tolerance of hydroxychloroquine in sarcoidosis-associated uveitis. Retrospective study on all patients with sarcoidosis-associated uveitis who were treated with hydroxychloroquine between 2003 and 2019 in a French university hospital. Twenty-seven patients with sarcoidosis-associated uveitis received hydroxychloroquine. The mean duration of treatment was 20.0 ± 10.9 months. At the end of the follow-up, hydroxychloroquine success was achieved in 15 (55.6%) patients. Four of them were also on oral corticosteroids, with a prednisone dose ≤5 mg/day. Under treatment, the median prednisone dose decreased from 20.0 (interquartile range (IQR), 7-25) to 5.0 (IQR, 3-6.5) mg/day ( Hydroxychloroquine appears as an interesting option in sarcoidosis-associated uveitis.
Sections du résumé
BACKGROUND/PURPOSE
UNASSIGNED
To assess the efficacy and tolerance of hydroxychloroquine in sarcoidosis-associated uveitis.
METHODS
UNASSIGNED
Retrospective study on all patients with sarcoidosis-associated uveitis who were treated with hydroxychloroquine between 2003 and 2019 in a French university hospital.
RESULTS
UNASSIGNED
Twenty-seven patients with sarcoidosis-associated uveitis received hydroxychloroquine. The mean duration of treatment was 20.0 ± 10.9 months. At the end of the follow-up, hydroxychloroquine success was achieved in 15 (55.6%) patients. Four of them were also on oral corticosteroids, with a prednisone dose ≤5 mg/day. Under treatment, the median prednisone dose decreased from 20.0 (interquartile range (IQR), 7-25) to 5.0 (IQR, 3-6.5) mg/day (
CONCLUSION
UNASSIGNED
Hydroxychloroquine appears as an interesting option in sarcoidosis-associated uveitis.
Identifiants
pubmed: 36749910
doi: 10.1080/09273948.2023.2165952
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM